Victory Capital Management »

Revance Therapeutics shares owned by Victory Capital Management

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Victory Capital Management from 13F filings

Historical chart of Victory Capital Management investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Victory Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Victory Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $51k 10k 4.92
2023-12-31 $93k 11k 8.79
2023-06-30 $14M 564k 25.31
2023-03-31 $19M 599k 32.21
2022-12-31 $876k 40k 22.00
2022-09-30 $1.1M 41k 26.99
2021-09-30 $264k 9.5k 27.84
2021-06-30 $294k 9.9k 29.64
2021-03-31 $285k 10k 27.94
2020-12-31 $278k 9.8k 28.34
2020-09-30 $235k 9.3k 25.19
2020-03-31 $118k 8.0k 14.78
2019-12-31 $178k 8.0k 22.37
2019-09-30 $82k 6.3k 12.94
2018-06-30 $1.6M 59k 27.45
2018-03-31 $1.9M 63k 30.79
2017-12-31 $2.0M 56k 35.75
2017-09-30 $956k 35k 27.54
2017-06-30 $921k 35k 26.41
2017-03-31 $739k 36k 20.80